Objective Although a number of effective psychotherapies have been identified for cancer patients, little is known about therapy processes, as they unfold the course of treatment and the role of therapy processes in treatment outcome. We used growth curve modeling to evaluate the associations between therapy processes and outcomes among gynecological cancer patients participating in 2 types of therapy. Conclusions For 2 types of treatment delivered to women diagnosed with gynecological cancer, patient-rated session progress and depressive symptoms rated over therapy sessions may serve as a yardstick that can be useful to therapists to gauge patient's response to treatment.
psychotherapy literature (eg, in previous studies 6, 7 ). The generic model of psychotherapy (GMP) provides a conceptual framework for studying these processes. [8] [9] [10] The GMP proposes 6 therapeutic change processes: therapy contract, therapeutic interventions, working alliance, therapeutic realizations, in-session impacts, and the sequential flow of the processes over the course of therapy. For the present study, we focus on 2 of these therapy processes-working alliance and the sequential flow of processes over the course of therapy. Working alliance is composed of the quality of the emotional bond between patient and therapist, degree of collaboration in setting therapeutic goals, and level of agreement about the ways of achieving these goals. 9, 11 Metaanalyses have shown that alliance is consistently associated with better therapy outcomes. 12 Sequential flow has been defined as the growth and change in both therapy processes and short-term outcomes (changes in distress in therapy) over the course of therapy that lead to posttreatment outcomes. 9 A unique element of the GMP is that short-term therapy outcomes are considered a key element of therapy process, in that they are conceptualized as an indicator of the sequential flow of the client's experience over the course of therapy. 10 Short-term therapy outcomes are defined as the patient's and/or therapist's evaluation of the impact of a session in both the progress made in sessions and the patient's emotional response to the session, which is typically evaluated as the client's postsession mood. 10 Short-term therapy outcomes have not received empirical attention in the psycho-oncology literature or in the general therapy literature, but they are important because they are associated with meaningful events such as the development of a strong working alliance 13 and posttreatment reductions in distress. 14 Most importantly, low levels of session progress predict premature therapy termination. 15, 16 A second element of the GMP is that this model postulates mediational associations between therapy processes and posttreatment outcomes. 9 This approach enriches our understanding of how therapy processes may work together to contribute to the success of therapy.
In addition to the well-known direct impact of working alliance on posttreatment outcomes 17 and the direct association between session progress and session outcome, 18, 19 the GMP proposes mediational roles for short-term session outcomes. Early working alliance predicts better treatment outcomes in part because it promotes the necessary improvements in progress and symptoms that accrue incrementally over sessions. 9, 10 These results suggest that evaluating the patterns of change in and associations between therapy processes (eg, working alliance),
short-term outcomes (eg, session progress and postsession depressive symptoms), and posttreatment outcomes may yield important information about how successful therapy works, particularly for psychological interventions for cancer patients. The primary goal of this study was to examine therapy processes, short-term outcomes, and posttreatment outcomes for patients recently diagnosed with gynecological cancer who received either brief supportive, client-centered counseling (SC) or a structured, prescriptive coping and communication skills intervention (CCI). Women undergoing treatment of gynecological cancers face numerous psychological and physical challenges. With the exception of an early stage cervical cancer, these cancers typically carry a poor prognosis. 20 The disease course is typically characterized by recurrences and multiple courses of treatment, which leads to pain and the deterioration in daily functioning. The radical abdominal surgery that many patients undergo disrupts body image, reduces sexual functioning, and induces menopause (if premenopausal). Given the difficult disease course and poor prognosis, it is not surprising that rates of distress are elevated. 21, 22 In a prior clinical trial, the efficacy of an SC and a structured, skillbased CCI in reducing depressive symptoms was illustrated. 23 In a subsequent trial, the original interventions were enhanced by adding one session to both interventions, increasing CCI's focus on coping with disease progression, adding more skill practice to CCI, and fostering more emotional expression and therapy theme development in SC.
We tested these enhanced interventions in a large randomized clinical trial, which forms the basis of the present study (Manne, unpublished data). These 2 treatments were selected because one was much more structured and focused on teaching coping skills (CCI), and the second was much less structured, client-centered, and focused on expressing and understanding emotional reactions to cancer.
This study had 3 aims. The first aim was to examine changes in progress over the course of the in-person sessions from both the patient and therapist perspectives (eg, sequential flow), as well as changes in depressive symptoms. We predicted that therapy progress would increase and depressive symptoms would decline over the sessions. We also predicted that perceived progress in one session would predict perceived progress in the next session. That is, progress would build overtime.
The second aim was to examine the association between early working alliance and short-term therapy outcomes. There were 2
hypotheses. First, we proposed that higher early working alliance would predict more progress and lower depressive symptoms over the sessions. The second hypothesis regarded a moderating role for working alliance in predicting the change in session progress overtime.
Specifically, we proposed that patients with higher levels of early working alliance would show a greater increase in progress and a steeper decline in depressive symptoms over sessions.
The third aim was to examine the interplay between working alliance, patient and therapist-rated session progress, and posttreatment outcomes. 24, 25 Consistent with GMP, we proposed that session progress would mediate the associations between working alliance and pretherapy to posttherapy changes in depressive symptoms. That is, higher working alliance would predict greater increases in session progress, which would, in turn, predict greater reductions in depressive symptoms after the treatment was complete. For each aim, we examined whether there were differences between the 2 treatment approaches. However, consistent with GMP and with our prior research suggesting equal effects for SC and CCI, 23 we did not predict differences between the 2 types of therapy.
2 | METHODS
| Participants and procedures
This is an analysis of data collected as part of a randomized clinical trial evaluating the efficacy of a coping and communication-enhancing intervention (CCI) versus an SC Intervention and usual care (Manne et al, unpublished data 
| Engagement in therapeutic interventions
In 
| Therapy process measure 2.4.1 | Early working alliance
Alliance was assessed using the Working Alliance Inventory (WAI). 30 Respondents rated their level of agreement to statements using a 7-point Likert-type scale. The subscales assessed the goals of therapy, the tasks of therapy, and the bond that develops between the clinician and patient. The WAI is a widely-used measure that has well established reliability and validity. 31 In the current study, the WAI was administered after the second session. Cronbach alpha was 0.90.
| Short-term therapy outcome measures 2.5.1 | Postsession depressive symptoms
Postsession depressive symptoms were assessed using the BDI. 27 The BDI is a 21-item scale, which has been widely used in therapy studies (scale range, 0-63). It was given after each session, and participants rated how they felt "now." Cronbach alphas ranged from 0.78 to 0.85 across the sessions.
| Patient-and therapist-rated session progress
The session progress scale of the therapy session report 32 2.6 | Long-term therapy outcome measure 2.6.1 | Depressive symptoms
Depressive symptoms were assessed using the BDI. 27 The scale was given preintervention and approximately 3 months later, after the psychological intervention treatment was completed. Cronbach alpha was 0.83 at both time points.
| Data analytic approach
Nonlinear growth model analyses of session outcomes and depression were conducted using multilevel modeling with SPSS Version 22. In these analyses, the 3 outcome variables reported for each session (ie, patient-reported session progress, therapist-reported session progress, and mood) were predicted to be a function of time in weeks since Session 1 (grand-mean centered so that the intercepts reflect the average value), a quadratic component of time in weeks, therapy type, and the interaction between the linear and quadratic components of time and therapy type. Because there was variation in the time between sessions across patients, we used individual-specific time intervals. All analyses included ethnicity (white/not white), education level (high school or less/some college or more), marital status (married/not married), patient age, time since diagnosis, functional impairment at Session 1 (assessed using the Cancer Rehabilitation Evaluation System), metastatic status, and number of sessions attended as covariates. In all analyses, the quantitative covariates were grand-mean centered, and therapy type and the categorical covariates were effect-coded.
Random effects for the growth models included a variance in the patient intercepts and a variance in the patient linear slopes for time (there was no sufficient variance to include a random quadratic effect of time). Because grand-mean centering and effect coding were used, the patient intercept variance measures patient-to-patient variation in average session progress or depression. The variance in the patient slopes specifies that there may be differences across patients in the degree of linear change of session progress or depression overtime.
The final random effect was a variance for the therapist intercepts, which accounted for nonindependence due to therapist because each therapist saw multiple patients.
To address Aim 2, measures of working alliance were added to the models. Analyses used nonlinear growth models that included the main effects and 2-and 3-way interactions between time, time-squared, therapy type, and the alliance variable, along with the same set of covariates described above. Significant interactions were decomposed using simple effects analyses in which we examined the effects of time for patients who were 1 SD above and below the mean on the moder- Table 2) . Correlations between the patient's average progress and the patients' reports of alliance were large, but those same correlations with therapist's average rating of session progress were modest in size. Finally, patient's postsession depressive symptoms declined significantly overtime (β = −.208), but the degree of decline was moderated overtime as shown by the significant effect for timesquared. There was no effect of therapy type. As can be seen in Table 4 , there was evidence that patients reporting higher functional impairment at the beginning of the study reported higher average depressive symptoms (β = .407), but patients with metastatic disease reported significantly lower depressive symptoms mediates the association between working alliance and therapy outcomes. As our key measure of outcome, we used the difference between BDI scores measured before treatment and after treatment that was completed.
| Descriptive information for variables
Results of these analyses indicated no evidence of mediation. This may be due to working alliance was not associated with the pretherapy to posttherapy change in the BDI, r = .014, p = .853. It is notable that the slopes for both patient-rated progress and postsession depressive symptoms over the course of therapy were significantly associated with change in BDI scores from pretreatment to posttreatment (for patient-reported progress, slopes r = −.152, p = .034 and for depression, slopes r = .375, p < .001). Thus, patients who reported stronger increases in session progress overtime showed greater declines in pretreatment to posttreatment BDI scores, and patients who reported stronger decreases in depressive symptoms over the course of sessions showed greater declines in BDI from pretreatment to posttreatment. However, contrary to our prediction, the slopes for therapist-reported session progress were not related to change in pretreatment to posttreatment BDI, r = .064, p = .372.
| DISCUSSION
Although a number of effective therapies have been identified for cancer patients, relatively little is known about therapy processes, as they unfold over the course of treatment. Moreover, little is known about the role of therapy processes in the efficacy of psychological interventions delivered to cancer patients. In the current study, we examined these 2 questions in a large randomized trial comparing 2 types of therapy delivered to cancer patients. There were 4 key findings. The first key finding regarded the positive short-term outcomes from both the patient and therapist perspectives. There was a steady increase in therapy progress over the course of both therapies, although CCI therapists perceived more progress for their patients, but these increases lessened over the course of therapy. Furthermore, changes in perceived progress built overtime; that is, progress from Time is measured in weeks since initial session. Therapy type is coded 1 = SC, −1 = CCI; ethnicity/race is coded white = 1 and not white = −1; education is coded post-high school = 1 and high school or less = −1; marital status is coded married = 1 and not married = −1; metastatic disease is coded 1 = metastasis and −1 = no metastasis. Time, time since diagnosis, age, functional impairment, and number of sessions attended were grand-mean centered.
*p < .05. **p < .01.
one session strongly predicted progress in the subsequent session.
Baseline demographic and medical characteristics did not predict changes in session progress, indicating that progress was not influenced by these patient characteristics. Depressive symptoms also steadily and significantly declined over the course of both treatments.
Unlike session progress, demographic and medical characteristics of patients predicted changes in depressive symptoms in that older patients, and patients with more physical impairment at the beginning of treatment showed less improvement over the course of both treatments. Taken together, there was a similar and positive impact of both treatments on short-term therapy outcomes. Our findings are consistent with the construct of treatment outcome expectancy, which assesses the extent to which patients anticipate benefiting from therapy and is an important predictor of treatment response. 34, 35 As patients perceive more progress, their expectancy for a beneficial treatment outcome increases.
The second key finding regards the role of these short-term The third key finding regards the role of working alliance in treatment outcomes. Consistent with prior research with the general population, higher early alliance predicted lower average depressive symptoms over the course of treatment 36 and greater session progress. 25 Our findings extend this literature in 2 ways. First, our work illustrates that early working alliance is less predictive of improvements in session progress when a strong alliance is perceived early in therapy than when a strong alliance has not been built early in therapy. This finding was contrary to our initial hypothesis. Second, there were differences in the effects of working alliance on perceived session progress depending on the type of therapy. When early alliance was low, patients reported significantly higher perceived therapy progress in the less structured SC. Less structured approaches such as SC may offer the opportunity to build alliance overtime. When early working alliance was high, the directive and prescriptive CCI was associated with higher perceived therapy progress, but this effect was not signif- have not yet formed a bond and may feel less comfortable, these activities may be experienced as less helpful. High alliance may mean that the patient is ready to begin working on understanding cognitions, restructuring them, and problem-solving. Future studies may benefit from evaluating differences in these associations when alliance is measured in the middle phase of therapy.
The fourth key finding regards the absence of the proposed mediational role of short-term outcomes (eg, session progress and depressive symptoms) in the association between early working alliance and pretherapy to posttherapy changes in depressive symptoms. These results were primarily due to the surprising finding that working alliance does not predict changes in depression pretreatment to posttreatment. As noted above, the slopes for session progress and postsession depressive symptoms were significantly associated with change in depression from pretreatment to posttreatment. Thus, although our findings may not support the role of early working alliance in long-term outcomes for these 2 therapy approaches, they suggest that therapists may be able to work with cancer patients to foster progress overtime even when working alliance is low.
The study has several limitations. Most participants were white and well-educated. The majority was diagnosed with ovarian cancer and had metastatic disease. It is possible that the therapy processes and outcomes would differ among minority patients, patients with less education, and women with early stage gynecological cancers. We had a relatively low rate of study acceptance, particularly among older patients, patients who were not as recently diagnosed, and patients diagnosed with nonovarian cancers, Our findings may not generalize to older, less recently diagnosed, and/or patients with nonovarian gynecological cancer. Most participants were not clinically depressed or seeking therapy. Our findings may have differed for depressed cancer patients seeking psychotherapy. The treatments were offered as part of a clinical trial where each session was rated for fidelity to the treatment model and closely supervised, and participants and therapists were aware. Whether the same associations would be seen outside of a research trial context is unknown. Working alliance was not assessed after every session and observer-rated measures of working alliance were not used. Our findings may have differed if we had used other measures or assessed changes in alliance. We did not assess other GMP processes such as therapeutic interventions, therapeutic realizations, and in-session impacts (eg, emotional experiencing in session). We did not collect medical information during the time frame that therapy was being delivered, and changes in therapeutic progress could be influenced by medical stressors. We also did not assess the amount of time participants who were on antidepressants that had been taking these medications, which may have influenced their perceptions of treatment progress.
Our findings have clinical implications for therapy with cancer patients. Short-term therapy outcomes, which can be conceptualized as progress monitoring, 37 are associated with posttreatment gains.
Although the measures used in this study are not as comprehensive as many next generation patient-reported therapy process monitoring scales (eg, BASIS-24 and in 1 study 38 ), assessing session progress and depressive symptoms after sessions is a useful tool to assess therapy response. If progress does not illustrate a steady increase over the first several sessions, therapists should process this occurrence with their patients. Therapists' perceptions of session progress are less useful markers of treatment outcome and should not replace patient reports.
Finally, for these 2 treatments for this particular cancer patient population, early working alliance predicted greater perceived progress but it did not contribute to pretreatment to posttreatment reduction in depressive symptoms. Whether this was due to the brief nature of the treatments or newly diagnosed cancer patients were being studied in a research setting, working alliance was not associated with treatment outcome.
